Carregant...

Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) affects approximately 25% of the global adult population and can progress to end-stage liver disease with life-threatening complications; however, no pharmacologic therapy has been approved. Drug delivery systems such as lipid nanocapsules (LNCs) are a very...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Control Release
Autors principals: Domingues, Inês, Michalowski, Cecilia Bohns, Marotti, Valentina, Zhang, Wunan, Van Hul, Matthias, Cani, Patrice D., Leclercq, Isabelle A., Beloqui, Ana
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science Publishers 2023
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7614370/
https://ncbi.nlm.nih.gov/pubmed/36907563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2023.03.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!